Discovery and structure-activity relationship of pyrrolo[2,1-f][1,2,4]triazines as inhibitors of phosphatidylinositol 3-kinase δ (PI3Kδ) for the treatment of immunological disorders

被引:0
|
作者
Shi, Qing [1 ]
Marcoux, David [1 ]
Liu, Qingjie [1 ]
Batt, Douglas [1 ]
Cornelius, Lyndon [1 ]
Srivastava, Anurag [1 ]
Cherney, Robert [1 ]
Qin, Lan-ying [1 ]
Ruan, Zheming [1 ]
Neels, James [1 ]
Bhide, Rajeev [1 ]
Li, Ling [1 ]
Bertrand, Myra Beaudoin [1 ]
Gong, Hua [1 ]
Watterson, Scott [1 ]
Pan, Jie [1 ]
Tang, Huaping [1 ]
Fan, Jingsong [1 ]
Yarde, Melissa [1 ]
Cvijic, Mary Ellen [1 ]
Obermeier, Mary [1 ]
Fura, Aberra [1 ]
Weigelt, Carolyn [1 ]
Galella, Michael [1 ]
Sack, Jack [1 ]
Muckelbauer, Jodi [1 ]
Gillooly, Kathleen [1 ]
McIntyre, Kim [1 ]
Ruan, Qian [1 ]
Poss, Michael [1 ]
Hynes, John [1 ]
Macor, John [1 ]
Carter, Percy [1 ]
Ruepp, Stefan [1 ]
Schieven, Gary [1 ]
Tino, Joseph [1 ]
机构
[1] Bristol Myers Squibb, Princeton, NJ USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
36
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors
    Wu, Peng
    Su, Yi
    Liu, Xiaowen
    Yang, Bo
    He, Qiaojun
    Hu, Yongzhou
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (09) : 2837 - 2844
  • [22] Differential Effects of Phosphatidylinositol 4-Kinase (PI4K) and 3-Kinase (PI3K) Inhibitors on Stomatal Responses to Environmental Signals
    Takahashi, Sho
    Monda, Keina
    Higaki, Takumi
    Hashimoto-Sugimoto, Mimi
    Negi, Juntaro
    Hasezawa, Seiichiro
    Iba, Koh
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [23] Bioactive Pyrrolo[2,1-f][1,2,4]triazines: Synthesis, Molecular Docking, In Vitro Cytotoxicity Assay and Antiviral Studies
    Mochulskaya, Nataliya N.
    Kotovskaya, Svetlana K.
    Butorin, Ilya I.
    Varaksin, Mikhail V.
    Charushin, Valery N.
    Rusinov, Vladimir L.
    Esaulkova, Yana L.
    Slita, Alexander V.
    Ilyina, Polina A.
    Zarubaev, Vladimir V.
    CHEMISTRY-SWITZERLAND, 2023, 5 (04): : 2657 - 2676
  • [24] Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo [2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase
    Mesaros, Eugen F.
    Angeles, Thelma S.
    Albom, Mark S.
    Wagner, Jason C.
    Aimone, Lisa D.
    Wan, Weihua
    Lu, Lihui
    Huang, Zeqi
    Olsen, Mark
    Kordwitz, Emily
    Haltiwanger, R. Curtis
    Landis, Amy J.
    Cheng, Mangeng
    Ruggeri, Bruce A.
    Ator, Mark A.
    Dorsey, Bruce D.
    Ott, Gregory R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (05) : 1047 - 1052
  • [25] Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38a MAP kinase inhibitors
    Dyckman, Alaric J.
    Li, Tianle
    Schieven, Gary
    Pitt, Sidney
    Zhang, Rosemary
    Shen, Ding Ren
    McKinnon, Murray
    McIntyre, Kim
    Gillooly, Kathleen
    Shuster, David
    Doweyko, Arthur
    Sack, John
    Zhang, Hongjian
    Marathe, Punit
    Barrish, Joel
    Dodd, John
    Leftheris, Katerina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [26] Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors
    Dyckman, Alaric J.
    Li, Tianle
    Pitt, Sidney
    Zhang, Rosemary
    Shen, Ding Ren
    McIntyre, Kim W.
    Gillooly, Kathleen M.
    Shuster, David J.
    Doweyko, Arthur M.
    Sack, John S.
    Kish, Kevin
    Kiefer, Susan E.
    Newitt, John A.
    Zhang, Hongjian
    Marathe, Punit H.
    McKinnon, Murray
    Barrish, Joel C.
    Dodd, John H.
    Schieven, Gary L.
    Leftheris, Katerina
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (15) : 4633 - 4637
  • [27] Discovery and bioactivity of 4-(2-arylpyrido[3′,2′:3,4]pyrrolo[1,2-f][1,2,4]-triazin-4-yl) morpholine derivatives as novel PI3K inhibitors
    Wang, Jia
    Wang, Xiang
    Chen, Yanhong
    Chen, Simeng
    Chen, Guang
    Tong, Linjiang
    Meng, Linghua
    Xie, Yuyuan
    Ding, Jian
    Yang, Chunhao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 339 - 342
  • [28] Synthesis of C-ribosyl imidazo[2,1-f][1,2,4]triazines as inhibitors of adenosine and AMP deaminases
    Dudfield, PJ
    Le, VD
    Lindell, SD
    Rees, CW
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1999, (20): : 2929 - 2936
  • [29] Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo [2,1-f] [1,2,4] triazine derivatives
    Xiang, Hao-Yue
    Chen, Yan-Hong
    Wang, Yi
    Zhang, Xi
    Ding, Jian
    Meng, Ling-Hua
    Yang, Chun-Hao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (12)
  • [30] Strategies to Mitigate the Bioactivation of 2-Anilino-7-Aryl-Pyrrolo[2,1-f][1,2,4]triazines: Identification of Orally Bioavailable, Efficacious ALK Inhibitors
    Mesaros, Eugen F.
    Thieu, Tho V.
    Wells, Gregory J.
    Zificsak, Craig A.
    Wagner, Jason C.
    Breslin, Henry J.
    Tripathy, Rabindranath
    Diebold, James L.
    McHugh, Robert J.
    Wohler, Ashley T.
    Quail, Matthew R.
    Wan, Weihua
    Lu, Lihui
    Huang, Zeqi
    Albom, Mark S.
    Angeles, Thelma S.
    Wells-Knecht, Kevin J.
    Aimone, Lisa D.
    Cheng, Mangeng
    Ator, Mark A.
    Ott, Gregory R.
    Dorsey, Bruce D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 115 - 125